Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments

Table 2

Distribution of IVIs based on drugs injected.

Drugs n (%)	Number of injections
Ranibizumab	5504 (54.6)
Aflibercept	3832 (38.0)
Dexamethasone	676 (6.7)
Pegaptanib	30 (0.3)
Bevacizumab	40 (0.4)
Ocriplasmin	1 (0.01)
Tot.	10083 (100)

Data are expressed as number and percentage.